drugset / Trial / NCT00209521

Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

NCT00209521

Phase 2 Completed 16 enrolled Eisai Inc. PPD Development, LP · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an exploratory clinical trial designed to examine the efficacy, safety and tolerability of fospropofol (AQUAVAN) Injection compared to propofol (DISOPRIVAN) Injectable Emulsion when used to preoperatively sedate, induce, and maintain general anesthesia and to postoperatively sedate patients undergoing elective coronary artery surgery.

Timeline

Start
2002-06
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule
Subject fospropofol Small molecule